ATE328103T1 - Mumbaistatin, verfahren zu seiner herstellung sowie seine verwendung als arzneimittel - Google Patents

Mumbaistatin, verfahren zu seiner herstellung sowie seine verwendung als arzneimittel

Info

Publication number
ATE328103T1
ATE328103T1 AT99927987T AT99927987T ATE328103T1 AT E328103 T1 ATE328103 T1 AT E328103T1 AT 99927987 T AT99927987 T AT 99927987T AT 99927987 T AT99927987 T AT 99927987T AT E328103 T1 ATE328103 T1 AT E328103T1
Authority
AT
Austria
Prior art keywords
mumbaistatin
production
medicinal product
medicinal
product
Prior art date
Application number
AT99927987T
Other languages
English (en)
Inventor
Nirogi Venkata Sat Ramakrishna
Keshavapura Hosamane Sre Swamy
Erra Koteswara Satya Vij Kumar
Manoj Maniram Singh Kushwaha
Sridevi Kota
Mythili Raman
Swati Dhananjay Tare
Sunil Kumar Deshmukh
Dietmar Schummer
Michael Kurz
Herbert Kogler
Original Assignee
Sanofi Aventis Deutschland
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Aventis Deutschland filed Critical Sanofi Aventis Deutschland
Application granted granted Critical
Publication of ATE328103T1 publication Critical patent/ATE328103T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P1/00—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes
    • C12P1/04—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes by using bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/465—Streptomyces
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/822—Microorganisms using bacteria or actinomycetales
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/822—Microorganisms using bacteria or actinomycetales
    • Y10S435/886—Streptomyces

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Diabetes (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Mycology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Endocrinology (AREA)
  • Obesity (AREA)
  • Emergency Medicine (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT99927987T 1998-06-24 1999-06-15 Mumbaistatin, verfahren zu seiner herstellung sowie seine verwendung als arzneimittel ATE328103T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP98111636 1998-06-24

Publications (1)

Publication Number Publication Date
ATE328103T1 true ATE328103T1 (de) 2006-06-15

Family

ID=8232164

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99927987T ATE328103T1 (de) 1998-06-24 1999-06-15 Mumbaistatin, verfahren zu seiner herstellung sowie seine verwendung als arzneimittel

Country Status (17)

Country Link
US (1) US6297043B1 (de)
EP (1) EP1090136B1 (de)
JP (1) JP4287593B2 (de)
KR (1) KR20010071564A (de)
CN (1) CN1306580A (de)
AR (1) AR020328A1 (de)
AT (1) ATE328103T1 (de)
AU (1) AU750509B2 (de)
BR (1) BR9912200A (de)
CA (1) CA2336135A1 (de)
DE (1) DE69931633T2 (de)
HU (1) HUP0102370A3 (de)
ID (1) ID27411A (de)
PL (1) PL345192A1 (de)
RU (1) RU2221870C2 (de)
TR (1) TR200003570T2 (de)
WO (1) WO1999067408A1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1192999C (zh) * 1999-10-25 2005-03-16 阿文蒂斯药物德国有限公司 用作葡萄糖－6－磷酸移位酶抑制剂的芳族二酮基衍生物
US7659102B2 (en) 2001-02-21 2010-02-09 Verenium Corporation Amylases, nucleic acids encoding them and methods for making and using them
ATE510023T1 (de) 2001-02-21 2011-06-15 Verenium Corp Enzyme mit alpha-amylase-aktivität und verfahren zu deren verwendung
US7741092B2 (en) 2002-10-31 2010-06-22 Verenium Corporation Amylases, nucleic acids encoding them and methods for making and using them
JP6465299B2 (ja) * 2015-05-29 2019-02-06 株式会社山田養蜂場本社 蜂蜜画分

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3905942A (en) 1973-06-22 1975-09-16 Gen Electric Method for making polyetherimides and products produced thereby
DE2429648A1 (de) * 1973-06-22 1975-01-16 Gen Electric Verfahren zum herstellen von polyaetherimiden
TW399041B (en) * 1992-09-09 2000-07-21 Hoechst Ag Substituted cyclohexane derivatives, the preparation and the use for treating diseases
TW255880B (de) * 1992-09-09 1995-09-01 Hoechst Ag

Also Published As

Publication number Publication date
BR9912200A (pt) 2001-11-20
CA2336135A1 (en) 1999-12-29
AU750509B2 (en) 2002-07-18
HUP0102370A2 (hu) 2001-10-28
HUP0102370A3 (en) 2003-10-28
CN1306580A (zh) 2001-08-01
DE69931633T2 (de) 2007-05-10
EP1090136B1 (de) 2006-05-31
RU2221870C2 (ru) 2004-01-20
US6297043B1 (en) 2001-10-02
DE69931633D1 (de) 2006-07-06
KR20010071564A (ko) 2001-07-28
AU4513799A (en) 2000-01-10
PL345192A1 (en) 2001-12-03
JP2002518057A (ja) 2002-06-25
JP4287593B2 (ja) 2009-07-01
WO1999067408A1 (en) 1999-12-29
ID27411A (id) 2001-04-05
AR020328A1 (es) 2002-05-08
TR200003570T2 (tr) 2001-04-20
EP1090136A1 (de) 2001-04-11

Similar Documents

Publication Publication Date Title
ATE302754T1 (de) Sulfonylcarboxamidderivate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
DE50102147D1 (de) Acylphenylharnstoffderivate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
DE69724142D1 (de) Sulfonamid-derivate, verfahren zur ihrer herstellung und ihre verwendung als arzneimittel
ATE315034T1 (de) Oxadiazole, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
DE59508149D1 (de) Aerogelhaltiges verbundmaterial, verfahren zu seiner herstellung sowie seine verwendung
ATE228499T1 (de) Benzamidoxim-derivate, zwischenprodukte und verfahren zu deren herstellung und deren verwendung als fungizide
ATE172203T1 (de) Erythromycinderivate, ihre verfahren zur herstellung und ihre verwendung als arzneimittel
ATE332898T1 (de) Neue dihydropteridinone, verfahren zu deren herstellung und deren verwendung als arzneimittel
ATE259805T1 (de) Als arzneimittel einsetzbare anticholinergika sowie verfahren zu deren herstellung
DE69712610D1 (de) Erythramicin-derivate, ihre verfahren zur herstellung und ihre verwendung als arzneimittel
ATE222236T1 (de) Neue guanidinderivate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
DE19880237D2 (de) Deformationselement, Verfahren zu seiner Herstellung und seine Verwendung
ATE232879T1 (de) Erythromycin-derivate, verfahren zu deren herstellung und deren verwendung als arzneimittel
DE59610963D1 (de) Neue phenylamidinderivate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
ATE304534T1 (de) Aminocarbonyl-substituierte benzimidazolderivate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
ATE301645T1 (de) Polycyclische thiazolidin-2-yliden amine, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
ATE267811T1 (de) Substituierte 1,2,3,4,5,6-hexahydro-2,6-methano-3-benzazocin- 0-ole, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
ATE328103T1 (de) Mumbaistatin, verfahren zu seiner herstellung sowie seine verwendung als arzneimittel
DE68912944D1 (de) Phenylpyrole, verwendbar als arzneimittel, verfahren zu ihrer herstellung und ihre verwendung.
DE50000560D1 (de) Substituierte 1,2,3,4,5,6-hexahydro-2,6-methano-3-benzazocin-10-ole, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
DE59902408D1 (de) Biphenylsulfonylcyanamide, verfahren zu ihrer herstellung und ihre verwendung als medikament
DE59608892D1 (de) Iminooxyphenylessigsäurederivate, verfahren und zwischenprodukte zu ihrer herstellung und ihre verwendung
ATE225854T1 (de) Vancoresmycin, verfahren zu dessen herstellung und dessen anwendung als arzneimittel
ATE217008T1 (de) Erythromycinderivate, verfahren zu ihrer herstellung, und ihrer verwendung als arzneimitteln
ATE302766T1 (de) Polycyclische 2-amino-dihydrothiazolsysteme, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties